Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

DAWN

Day One Biopharmaceuticals Inc

Dec 13 • 04:00PM ET

12.75

Dollar change -0.06
Percentage change -0.47	%

Healthcare • Biotechnology • USA • NASD

Peers: VRTX NBIX BPMC SRPT EXEL FATE IGMS KURA BHVN PBYI

| Held by: VTI IWM XBI VXF VB VBR IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.01	Insider Own	28.00%	Shs Outstand	100.81M	Perf Week	-7.27%
Market Cap	1.28B	Forward P/E	-	EPS next Y	-1.00	Insider Trans	-0.59%	Shs Float	72.61M	Perf Month	-14.14%
Income	-84.29M	PEG	-	EPS next Q	-0.46	Inst Own	81.28%	Short Float	26.84%	Perf Quarter	-6.46%
Sales	101.95M	P/S	12.55	EPS this Y	68.09%	Inst Trans	29.36%	Short Ratio	17.74	Perf Half Y	1.11%
Book/sh	5.51	P/B	2.31	EPS next Y	-31.76%	ROA	-16.61%	Short Interest	19.49M	Perf Year	-10.02%
Cash/sh	5.56	P/C	2.29	EPS next 5Y	-	ROE	-17.84%	52W Range	11.94 - 18.07	Perf YTD	-12.67%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-84.59%	ROI	-15.11%	52W High	-29.44%	Beta	-1.51
Dividend TTM	-	Quick Ratio	14.55	Sales past 5Y	0.00%	Gross Margin	97.53%	52W Low	6.78%	ATR (14)	0.58
Dividend Ex-Date	-	Current Ratio	14.62	EPS Y/Y TTM	55.68%	Oper. Margin	-207.40%	RSI (14)	35.84	Volatility	3.15% 4.31%
Employees	155	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-82.68%	Recom	1.20	Target Price	37.00
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	171.17%	Payout	-	Rel Volume	0.81	Prev Close	12.81
Sales Surprise	229.17%	EPS Surprise	220.41%	Sales Q/Q	-	Earnings	Oct 30 AMC	Avg Volume	1.10M	Price	12.75
SMA20	-5.20%	SMA50	-10.17%	SMA200	-11.86%	Trades		Volume	889,119	Change	-0.47%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-09-24	Reiterated	Needham	Buy	$32 → $33
Aug-01-24	Upgrade	BofA Securities	Underperform → Buy	$11 → $24
Apr-24-24	Reiterated	Needham	Buy	$30 → $33
Apr-25-23	Downgrade	BofA Securities	Buy → Underperform	$34 → $9
Feb-08-23	Initiated	CapitalOne	Overweight	$40
Feb-03-23	Initiated	Oppenheimer	Perform
Dec-15-22	Initiated	H.C. Wainwright	Buy	$35
Dec-14-22	Initiated	Needham	Buy	$40
Dec-05-22	Initiated	Goldman	Buy	$45
Dec-01-22	Initiated	BofA Securities	Buy	$34

Dec-06-24 08:53PM	Instagram locks out developers of third-party consumer apps (TechCrunch)
Nov-27-24 10:18AM	Why Is Day One Biopharmaceuticals Inc. (DAWN) Among the Best Up and Coming Stocks to Buy According to Analysts? (Insider Monkey)
Nov-20-24 04:30PM	Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development (GlobeNewswire)
Nov-18-24 08:30AM	Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-06-24 09:55AM	Wall Street Analysts See a 136.83% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? (Zacks)
05:20PM	Loading…
Oct-30-24 05:20PM	Day One Biopharmaceuticals, Inc. (DAWN) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:01PM	Day One Reports Third Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
Oct-21-24 09:55AM	Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 140.71%: Read This Before Placing a Bet (Zacks)
Oct-16-24 08:44AM	Day One Biopharmaceuticals (DAWN): Advancing Targeted Therapies for Pediatric Glioma (Insider Monkey)
08:30AM	Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024 (GlobeNewswire)
Oct-01-24 08:00PM	At What Oil Price Will Shale Drillers Stop Drilling? (Oilprice.com)
Aug-27-24 12:49PM	Taylor Fritzs Girlfriend Morgan Riddle Opts for Classic Little Black Dress on Day One of the U.S. Open 2024 (WWD)
Aug-19-24 11:15AM	Jeff Bezos Said 'I Predict One Day Amazon Will Fail' And Claims Large Companies Only Last '30-Plus Years' Guess How Old Amazon Is? (Benzinga)
Aug-14-24 11:46AM	Bank of America Says Buy These 3 Stocks for a Double-Digit Rally (InvestorPlace)
Jul-30-24 01:52PM	DAWN Stock Earnings: Day One Biopharmaceutical Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
08:40AM	Loading…
08:40AM	Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Day One Reports Second Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
07:00AM	Day One Announces Oversubscribed $175.0 Million Private Placement (GlobeNewswire)
Jul-25-24 11:53AM	Ipsen outlines $461m for ex-US rights to Day Ones glioma therapy (Pharmaceutical Technology)
12:58AM	Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor (GlobeNewswire)
Jun-27-24 09:51AM	Lupita Nyongo Shimmers in Sequined Off-the-shoulder Prada Jumpsuit and Satin Miniskirt at A Quiet Place: Day One Premiere (WWD)
Jun-24-24 04:50PM	Lupita Nyongo Gives Power Suiting a Sensual Spin in Double-breasted Blazer and High-waisted Shorts for A Quiet Place: Day One Photo Call (WWD)
Jun-22-24 04:11AM	Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN) (GuruFocus.com)
Jun-19-24 12:14PM	Day One targets the growing ADC market with MabCare acquisition (Pharmaceutical Technology)
10:29AM	Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up (Zacks)
Jun-18-24 08:30AM	Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers (GlobeNewswire) +11.31%
Jun-11-24 07:46AM	Exclusive: Day One Ventures closes its third fund at $150 million (Fortune)
May-30-24 08:30AM	Day One Announces Sale of Priority Review Voucher for $108 Million (GlobeNewswire)
May-07-24 09:25AM	HC Wainwright Adjusts Price Target on Day One Biopharmaceuticals to $40 From $50, Maintains Buy Rating (MT Newswires)
May-06-24 10:53PM	DAWN Stock Earnings: Day One Biopharmaceutical Misses EPS for Q1 2024 (InvestorPlace)
04:30PM	Loading…
04:30PM	Day One Reports First Quarter 2024 Financial Results and Corporate Progress (GlobeNewswire)
03:22AM	Day One Biopharmaceuticals Insider Sold Shares Worth $1,081,191, According to a Recent SEC Filing (MT Newswires)
May-04-24 02:31AM	Insider Sale at Day One Biopharmaceuticals Inc (DAWN) (GuruFocus.com)
Apr-23-24 03:56PM	Day One's OJEMDA (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor (GlobeNewswire) +8.19%
03:54PM	Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment (MT Newswires)
Mar-13-24 07:07AM	13 Best Biotech Stocks To Buy Under $20 (Insider Monkey)
Feb-28-24 04:32AM	Day One Biopharmaceuticals Inc (DAWN) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com)
Feb-26-24 04:30PM	Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress (GlobeNewswire) +11.05%
Jan-31-24 05:12PM	Dwayne 'The Rock' Johnson's net worth: How the new TKO Board Member built his wealth from $7 (TheStreet)
Jan-17-24 08:00AM	Day One Announces Two New Appointments to Board of Directors (GlobeNewswire)
Dec-19-23 08:00AM	Day One to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-27-23 10:00AM	Milei to Send Shock Package to Argentinas Congress on Day One (Bloomberg)
Nov-17-23 07:00AM	Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine (GlobeNewswire)
Nov-14-23 08:00AM	Day One to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire) +6.85%
Nov-06-23 05:16PM	Day One Biopharmaceuticals Inc (DAWN) Reports Q3 2023 Financial Results and Corporate Progress (GuruFocus.com)
04:30PM	Day One Reports Third Quarter 2023 Financial Results and Corporate Progress (GlobeNewswire)
Nov-04-23 12:16PM	12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds (Insider Monkey)
Oct-30-23 07:27PM	Apples Journal app has arrived heres whats good and bad (TechCrunch) +17.01%
08:00AM	Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) (GlobeNewswire)
Oct-23-23 01:20PM	Hedge Fund and Insider Trading News: Bill Ackman, Nelson Peltz, Dan Loeb, Coltrane Asset Management, Day One Biopharmaceuticals, Inc. (DAWN), Central Securities Corp. (CET), and More (Insider Monkey)
Oct-20-23 10:20AM	Tesla Stock Had a Horrible Day. Heres What Comes Next. (Barrons.com)
Sep-29-23 12:43PM	25 Biggest Stocks with Negative Beta (Insider Monkey)
Sep-11-23 09:02PM	Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) (GlobeNewswire)
Aug-16-23 08:00AM	Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience (GlobeNewswire)
Aug-10-23 02:28PM	FMR LLC Reduces Stake in Day One Biopharmaceuticals Inc (GuruFocus.com)
Aug-07-23 04:30PM	Day One Reports Second Quarter 2023 Financial Results and Corporate Progress (GlobeNewswire) +5.66%
Jun-17-23 08:29AM	Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) is favoured by institutional owners who hold 54% of the company (Simply Wall St.)
Jun-12-23 08:00AM	Day One Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Jun-08-23 12:38PM	Biotech Stock Roundup: GSK Provides Updates, Biogen to Discontinue Study & More (Zacks) -8.19%
07:00AM	KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA (PR Newswire)
Jun-06-23 10:31PM	Day One Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:01PM	Day One Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jun-05-23 04:06PM	ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips (Investor's Business Daily)
12:30PM	Why Shares of Day One Pharmaceuticals Are Up Monday (Motley Fool)
Jun-04-23 12:45PM	Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (GlobeNewswire)
May-30-23 08:00AM	Day One to Participate in the Goldman Sachs 44th Annual Healthcare Conference (GlobeNewswire)
May-25-23 08:30PM	CORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
05:00PM	Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-01-23 09:00AM	Day One Reports First Quarter 2023 Financial Results and Corporate Progress (GlobeNewswire) +16.69%
Apr-30-23 09:57AM	We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth (Simply Wall St.)
Apr-26-23 09:31AM	Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) +8.18%
Apr-21-23 01:02PM	Leaked: Apple's Secret Health Play Could Push Out Smaller Apps (TheStreet.com) +5.38%
11:44AM	A Daily Journal For iPhone: Apple Weighs Day One-Like Health App For iPhone Users (Benzinga)
Apr-12-23 08:00AM	Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress (GlobeNewswire)
Mar-21-23 05:30AM	Credit Suisse sets up Hong Kong-style hawker stalls to treat investors to dim sum, pineapple buns at what could be its swan song conference (South China Morning Post)
Mar-06-23 04:30PM	Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress (GlobeNewswire) +7.46%
Feb-27-23 08:00AM	Day One to Participate in the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-15-23 10:24AM	Billionaire Steve Cohen Pulls the Trigger on These 2 Strong Buy Stocks (TipRanks)
Jan-09-23 08:57AM	Day One Biopharmaceuticals Shares Jump As Pediatric Brain Cancer Candidate Shows Encouraging Responses (Benzinga)
08:30AM	Day One to submit its glioma drug to the FDA this year (MarketWatch)
Jan-08-23 05:00PM	Day One Announces Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma (GlobeNewswire)
Jan-03-23 01:04AM	Startups spring from ashes of Big Tech purge (Reuters) -5.90%
01:00AM	REFILE-FOCUS-Startups spring from ashes of Big Tech purge (Reuters)
Dec-20-22 08:00AM	Day One to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-14-22 01:02PM	This Pediatric Cancer Company Makes It To Analyst's Conviction List (Benzinga) +7.51%
Dec-05-22 09:05AM	Is This the DAWN of a Rally for Day One Biopharmaceuticals? (TheStreet.com)
Nov-21-22 08:33AM	We're Not Very Worried About Day One Biopharmaceuticals' (NASDAQ:DAWN) Cash Burn Rate (Simply Wall St.)
Nov-17-22 07:00AM	Day One to Participate in the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire)
Nov-11-22 07:00AM	Day One Announces Upcoming Presentations at 2022 Society for Neuro-Oncology Annual Meeting (GlobeNewswire)
Nov-07-22 04:30PM	Day One Reports Third Quarter 2022 Financial Results and Corporate Progress (GlobeNewswire)
Oct-17-22 08:00AM	Day One Announces Cooperative Research and Development Agreement with National Cancer Institute to Expand Development of Tovorafenib (DAY101) (GlobeNewswire) -5.80%
Sep-12-22 08:30AM	Day One Appoints Garry Nicholson as Chairman of the Board of Directors (GlobeNewswire)
Aug-09-22 08:50AM	Here's What Could Help Day One Biopharmaceuticals, Inc. (DAWN) Maintain Its Recent Price Strength (Zacks) -6.72%
Aug-04-22 04:30PM	Day One Reports Second Quarter 2022 Financial Results and Corporate Progress (GlobeNewswire) +6.90% +15.60%
Aug-02-22 08:00AM	Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference (GlobeNewswire) +6.63%
Jul-29-22 11:33AM	What Percentage Of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Do Insiders Own? (Simply Wall St.)
Jul-18-22 09:55AM	Wall Street Analysts Think Day One Biopharmaceuticals, Inc. (DAWN) Could Surge 85%: Read This Before Placing a Bet (Zacks) -5.28%
Jun-30-22 01:08PM	Biotech ETF Tops in June: 5 Stocks That Outperform (Zacks)
Jun-23-22 07:26PM	Insiders Are Flashing a Strong Buy Signal for These 2 Stocks (TipRanks) +8.99%
Jun-21-22 08:30AM	Day One Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares (GlobeNewswire)

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Blackman Samuel C.	HEAD OF R&D	Dec 10 '24	Sale	13.31	30,000	399,339	1,034,015	Dec 12 04:06 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Nov 18 '24	Sale	13.21	10,554	139,420	108,377	Nov 19 04:36 PM
Blackman Samuel C.	HEAD OF R&D	Nov 18 '24	Sale	13.21	2,206	29,142	1,064,015	Nov 19 04:34 PM
Dubow Adam	GENERAL COUNSEL	Nov 18 '24	Sale	13.21	3,165	41,810	32,162	Nov 19 04:32 PM
York Charles N II	COO, CFO AND SECRETARY	Nov 18 '24	Sale	13.21	2,602	34,373	240,133	Nov 19 04:30 PM
SAMUEL BLACKMAN	Officer	Nov 18 '24	Proposed Sale	13.21	2,206	29,142		Nov 18 04:22 PM
JEREMY BENDER	Officer	Nov 18 '24	Proposed Sale	13.21	10,554	139,420		Nov 18 04:21 PM
Blackman Samuel C.	HEAD OF R&D	Nov 08 '24	Sale	16.17	18,255	295,229	1,067,535	Nov 12 04:57 PM
Blackman Samuel C.	HEAD OF R&D	Nov 11 '24	Sale	16.10	10,000	160,994	1,057,535	Nov 12 04:57 PM
SAMUEL BLACKMAN	Officer	Nov 11 '24	Proposed Sale	16.39	50,000	819,500		Nov 12 07:49 AM
Blackman Samuel C.	HEAD OF R&D	Nov 07 '24	Sale	16.03	11,245	180,287	1,085,790	Nov 08 04:15 PM
Blackman Samuel C.	HEAD OF R&D	Oct 31 '24	Sale	16.02	500	8,010	1,097,035	Nov 04 05:24 PM
SAMUEL BLACKMAN	Officer	Oct 31 '24	Proposed Sale	14.47	30,000	434,100		Oct 31 04:27 PM
Blackman Samuel C.	HEAD OF R&D	Sep 10 '24	Sale	14.22	30,000	426,675	1,097,535	Sep 12 04:48 PM
Dubow Adam	GENERAL COUNSEL	Aug 16 '24	Sale	14.00	3,202	44,825	26,928	Aug 19 06:12 PM
York Charles N II	COO, CFO AND SECRETARY	Aug 16 '24	Sale	14.00	2,633	36,860	232,485	Aug 19 06:07 PM
Blackman Samuel C.	HEAD OF R&D	Aug 16 '24	Sale	14.00	2,232	31,246	1,127,535	Aug 19 05:59 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Aug 16 '24	Sale	14.00	10,681	149,524	98,932	Aug 19 05:53 PM
JEREMY BENDER	Officer	Aug 16 '24	Proposed Sale	14.00	10,681	149,524		Aug 16 05:23 PM
SAMUEL BLACKMAN	Officer	Aug 16 '24	Proposed Sale	14.00	2,232	31,246		Aug 16 05:17 PM
Blackman Samuel C.	HEAD OF R&D	Jul 16 '24	Sale	16.01	20,000	320,226	1,121,081	Jul 17 04:53 PM
Ramasastry Saira	Director	Jun 21 '24	Sale	13.19	10,000	131,877	40,485	Jun 21 07:17 PM
Blackman Samuel C.	HEAD OF R&D	Jun 10 '24	Sale	12.62	30,000	378,588	1,141,081	Jun 12 04:29 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	May 16 '24	Sale	16.08	7,873	126,588	654,728	May 17 06:27 PM
Blackman Samuel C.	HEAD OF R&D	May 16 '24	Sale	16.08	2,267	36,450	1,171,081	May 17 06:18 PM
York Charles N II	COO, CFO AND SECRETARY	May 16 '24	Sale	16.08	2,675	43,011	224,868	May 17 06:15 PM
Dubow Adam	GENERAL COUNSEL	May 16 '24	Sale	16.08	3,253	52,304	21,731	May 17 06:11 PM
Blackman Samuel C.	HEAD OF R&D	May 10 '24	Sale	16.37	10,000	163,743	1,164,662	May 14 06:13 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	May 01 '24	Sale	17.88	70,051	1,252,183	651,762	May 03 06:48 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	May 03 '24	Sale	17.85	9,154	163,417	642,602	May 03 06:48 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	May 02 '24	Sale	17.94	6	108	651,756	May 03 06:48 PM
York Charles N II	COO, CFO AND SECRETARY	May 01 '24	Sale	17.89	52,183	933,397	225,571	May 03 06:44 PM
York Charles N II	COO, CFO AND SECRETARY	May 03 '24	Sale	17.85	8,078	144,214	217,293	May 03 06:44 PM
York Charles N II	COO, CFO AND SECRETARY	May 02 '24	Sale	17.90	200	3,579	225,371	May 03 06:44 PM
Blackman Samuel C.	HEAD OF R&D	Apr 18 '24	Sale	16.02	10,000	160,163	1,174,662	Apr 22 06:36 PM
Blackman Samuel C.	HEAD OF R&D	Mar 25 '24	Sale	16.01	10,000	160,055	1,184,662	Mar 26 06:09 PM
Blackman Samuel C.	HEAD OF R&D	Mar 11 '24	Sale	15.24	30,000	457,314	1,194,662	Mar 13 04:24 PM
Blackman Samuel C.	HEAD OF R&D	Feb 27 '24	Sale	16.11	20,000	322,166	1,224,662	Feb 28 07:55 PM
Dubow Adam	GENERAL COUNSEL	Feb 16 '24	Sale	15.25	3,242	49,434	16,585	Feb 20 06:48 PM
York Charles N II	COO, CFO AND SECRETARY	Feb 16 '24	Sale	15.25	2,666	40,651	277,754	Feb 20 06:36 PM
Blackman Samuel C.	HEAD OF RESEARCH AND DEVELOPME	Feb 16 '24	Sale	15.25	2,258	34,430	1,244,662	Feb 20 06:26 PM
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Feb 16 '24	Sale	15.25	7,615	116,114	721,813	Feb 20 06:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DAWN

Day One Biopharmaceuticals Inc

Upgrade your FINVIZ experience